AAPM | COMP Joint Meeting · Vancouver · July 19-22

Find the sessions, people, and ideas worth planning around.

AAPM Explorer turns the official 2026 Confex program into a fast research map: search abstracts, track institutions, scan topic momentum, and build a conflict-aware calendar.

Browse submissions Browse calendar Institution map

Year over year

2025 to 2026

Same Confex-derived metrics
Abstracts 2869 +453 (+18.8%) 2416 in 2025 Sessions 229 -50 (-17.9%) 279 in 2025 Authors 7751 +1533 (+24.7%) 6218 in 2025 Prolific authors 1396 +232 (+19.9%) 1164 in 2025 Institution hubs 643 +66 (+11.4%) 577 in 2025 Countries 68 -14 (-17.1%) 82 in 2025

Institution movement

Largest output gains

1BC Cancer+84 2UT Southwestern Medical Center+42 3Stanford University+36 4Shandong First Medical University and Shandong Academy of Medical Sciences+33 5University of British Columbia+29 6Mayo Clinic+28
Poster Program 1942 Invited Program 657 Proffered Program 492 General Events 7

Program cockpit

What to plan around

67% poster-heavy
1928posters to browse 941talk abstracts 100%scheduled on calendar
Poster Program 1942 Invited Program 657 Proffered Program 492 General Events 7

Topic shape

Category density

1897 Therapy Physics 501 Diagnostic and Interventional Radiology Physics 205 Radiopharmaceuticals, Theranostics, and Nuclear Medicine 151 Professional 39 Clinical Trials Specialty Program 27 Education (Innovation in Medical Physics: Arthur Boyer Award) 13 Keynote Events 8 TH- Brachytherapy

Spotlight · Lucky sample

Explore a random abstract set

A random slice of abstracts with full text.

Roll abstracts View all
Poster GPD-T-418 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
Prognostic Value of Clinical and FDG-PET/CT-Derived Parameters for Overall Survival In Oligometastatic Non–Small Cell Lung Cancer Patients

Prognostic stratification of patients with oligometastatic (1–5 metastases) non–small cell lung cancer (omNSCLC) remains a challenging yet important task. This study evaluates the prognostic value of clinical and FDG-PET-derived...

Maksym Fritsak
Therapy Physics 0 people interested
Poster GPD-T-876 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
Progression-Free Survival Prediction Using Computed Tomography Foundation Models In Stereotactic Ablative Radiotherapy–Treated Oligometastatic Renal Cell Carcinoma

Stereotactic ablative radiotherapy (SAbR) has demonstrated efficacy in controlling oligometastatic renal cell carcinoma (omRCC) with safely delayed systemic therapy. However, a subset of patients has limited benefit from SAbR, wh...

Bowen Jing, PhD
Therapy Physics 0 people interested

Trending

Topic momentum

clinical trials 15 education 15 artificial intelligence (AI) 15 brachytherapy 11 radiation therapy 8 dosimetry 8 breast 7 protons 6 MRI 6 adaptive radiotherapy 6 quality control 6 quality assurance 6

Institutions

Output leaders

643 hubs · 1523 normalized affiliations · 68 countries
1The University of Texas MD Anderson Cancer Center161 2UT Southwestern Medical Center151 3Mayo Clinic120 4Stanford University100 5BC Cancer95 6University of Wisconsin-Madison93 7Memorial Sloan Kettering Cancer Center87 8Emory University77